In patients treated with SGLT2-inhibitors, DKA is precipitated by inadequate/discontinued insulin therapy, low-carbohydrate intake, prolonged fasting, alcohol consumption, severe infections/illness/surgery, and conditions which increase counter-regulatory hormone production (glucagon, catecholamines, cortisol, and growth hormone) [5]. The gene discussed is INS; the disease is infection.